- Lantheus Announces Executive Appointments to Accelerate Innovation
- Lantheus Reports First Quarter 2024 Financial Results
- Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
- Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
- Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients
- Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer
- Lantheus to Present at the TD Cowen 44th Annual Health Care Conference
- Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
- Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging
- Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time
More ▼
Key statistics
On Friday, Lantheus Holdings Inc (0L8:STU) closed at 73.26, -20.11% below its 52-week high of 91.70, set on May 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 74.30 |
---|---|
High | 74.30 |
Low | 73.26 |
Bid | 72.50 |
Offer | 73.98 |
Previous close | 73.12 |
Average volume | 0.00 |
---|---|
Shares outstanding | 69.31m |
Free float | 67.53m |
P/E (TTM) | 12.16 |
Market cap | 5.52bn USD |
EPS (TTM) | 6.55 USD |
Data delayed at least 15 minutes, as of May 17 2024.
More ▼